ArticleFrontiers in oncology2024

Case report: Successful radical surgery following complete pathological remission of advanced HCC with Tislelizumab/Lenvatinib plus TACE.

Yong Xie et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.